BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21453380)

  • 21. Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials.
    Price A; Rayner L; Okon-Rocha E; Evans A; Valsraj K; Higginson IJ; Hotopf M
    J Neurol Neurosurg Psychiatry; 2011 Aug; 82(8):914-23. PubMed ID: 21558287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.
    Furukawa TA; Cipriani A; Atkinson LZ; Leucht S; Ogawa Y; Takeshima N; Hayasaka Y; Chaimani A; Salanti G
    Lancet Psychiatry; 2016 Nov; 3(11):1059-1066. PubMed ID: 27726982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial.
    Zuidersma M; Chua KC; Hellier J; Voshaar RO; Banerjee S;
    Am J Geriatr Psychiatry; 2019 Sep; 27(9):920-931. PubMed ID: 31084994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis.
    Rocha FL; Murad MG; Stumpf BP; Hara C; Fuzikawa C
    J Psychopharmacol; 2013 May; 27(5):417-23. PubMed ID: 23427193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies.
    Chan JYC; Yiu KKL; Kwok TCY; Wong SYS; Tsoi KKF
    J Am Med Dir Assoc; 2019 Mar; 20(3):279-286.e1. PubMed ID: 30711460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy.
    Bschor T; Baethge C
    Acta Psychiatr Scand; 2010 Mar; 121(3):174-9. PubMed ID: 19703121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-Analysis of Placebo Response in Adult Antidepressant Trials.
    Li F; Nasir M; Olten B; Bloch MH
    CNS Drugs; 2019 Oct; 33(10):971-980. PubMed ID: 31573058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desvenlafaxine for the acute treatment of depression: a systematic review and meta-analysis.
    Laoutidis ZG; Kioulos KT
    Pharmacopsychiatry; 2015 Sep; 48(6):187-99. PubMed ID: 26205685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness.
    Gill D; Hatcher S
    J Psychosom Res; 1999 Aug; 47(2):131-43. PubMed ID: 10579497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are the chances for personalised treatment with antidepressants? Detection of patient-by-treatment interaction with a variance ratio meta-analysis.
    Plöderl M; Hengartner MP
    BMJ Open; 2019 Dec; 9(12):e034816. PubMed ID: 31874900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploratory review of placebo characteristics reported in randomised placebo controlled antidepressant drug trials.
    Hughes J; Gabbay M; Funnell E; Dowrick C
    Pharmacopsychiatry; 2012 Jan; 45(1):20-7. PubMed ID: 21979925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant-placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity.
    Khan A; Bhat A; Faucett J; Kolts R; Brown WA
    Psychopharmacology (Berl); 2011 Apr; 214(4):961-5. PubMed ID: 21125396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
    Ogawa Y; Furukawa TA; Takeshima N; Hayasaka Y; Atkinson LZ; Tanaka S; Cipriani A; Salanti G
    Int Clin Psychopharmacol; 2018 Mar; 33(2):66-72. PubMed ID: 29064911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for Depression Posttraumatic Brain Injury: A Meta-analysis.
    Salter KL; McClure JA; Foley NC; Sequeira K; Teasell RW
    J Head Trauma Rehabil; 2016; 31(4):E21-32. PubMed ID: 26479398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nocebo in clinical trials for depression: a meta-analysis.
    Mitsikostas DD; Mantonakis L; Chalarakis N
    Psychiatry Res; 2014 Jan; 215(1):82-6. PubMed ID: 24210741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effects of antidepressive drugs among the patients with memory disturbances--a systematic review].
    Saarinen J; Kivelä SL; Räihä I
    Duodecim; 2010; 126(21):2503-9. PubMed ID: 21171475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis.
    Jackson JL; O'Malley PG; Tomkins G; Balden E; Santoro J; Kroenke K
    Am J Med; 2000 Jan; 108(1):65-72. PubMed ID: 11059442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of depression after stroke: a systematic review of pharmacological therapies.
    Hackett ML; Anderson CS; House AO
    Stroke; 2005 May; 36(5):1098-103. PubMed ID: 15802637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies.
    Pan YJ; Wu CS; Gau SS; Chan HY; Banerjee S
    Dement Geriatr Cogn Disord; 2014; 37(3-4):125-40. PubMed ID: 24157687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression in Alzheimer's disease. Pathophysiology, diagnosis, and treatment.
    Modrego PJ
    J Alzheimers Dis; 2010; 21(4):1077-87. PubMed ID: 21504132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.